Related Experiment Video
Updated: May 11, 2026

HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis
Published on: November 11, 2022
Legislations combating counterfeit drugs in Hong Kong.
1The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong.
Hong Kong
Area of Science:
- Pharmaceutical law
- Public health policy
- Criminal justice
Background:
- Counterfeit drugs pose a significant threat to public health.
- Existing legislation in Hong Kong requires comprehensive review to effectively combat counterfeit pharmaceuticals.
Purpose of the Study:
- To analyze current legislation and judicial practices against counterfeit drugs in Hong Kong.
- To understand stakeholder perceptions on the effectiveness of anti-counterfeit drug laws.
Main Methods:
- Review of Hong Kong ordinances and court cases related to counterfeit drugs.
- In-depth interviews with key stakeholders to gather insights on legislative effectiveness.
Main Results:
- Identified key ordinances (Trade Marks, Patents, Trade Descriptions, Pharmacy and Poisons) combating counterfeit drugs.
- Determined sentencing criteria influenced by intent, drug quantity, criminal history, and cooperation.
- Documented stakeholder views on penalties, enforcement, and the scale of the counterfeit drug issue.
Conclusions:
- Advocates for a specific law with stringent penalties to address legislative gaps.
- Recommends supplementary non-legal measures including public education and enhanced pharmacist roles.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Products: Biologics, Biosimilars and Interchangeables
Clinically Relevant Drug Product Specifications: Methods of Establishment
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

